Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

NCT02151695 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Naive Patients With Uncomplicated Proliferative Diabetic Retinopathy

Interventions

PROCEDURE: panretinal photocoagulation
DRUG: Aflibercept intravitreal injections

Sponsor

Poitiers University Hospital